Q32 Bio Inc. 8-K Filing
Ticker: QTTB · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1661998
| Field | Detail |
|---|---|
| Company | Q32 Bio Inc. (QTTB) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2025 |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Q32 Bio Inc. (ticker: QTTB) to the SEC on Dec 19, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.0001 (ich registered Common stock, par value $0.0001 per share QTTB The Nasdaq Capital M).
How long is this filing?
Q32 Bio Inc.'s 8-K filing is 2 pages with approximately 485 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 485 words · 2 min read · ~2 pages · Grade level 12.3 · Accepted 2025-12-19 16:06:12
Key Financial Figures
- $0.0001 — ich registered Common stock, par value $0.0001 per share QTTB The Nasdaq Capital M
Filing Documents
- d29360d8k.htm (8-K) — 22KB
- 0001193125-25-326821.txt ( ) — 129KB
- qttb-20251217.xsd (EX-101.SCH) — 3KB
- qttb-20251217_lab.xml (EX-101.LAB) — 17KB
- qttb-20251217_pre.xml (EX-101.PRE) — 11KB
- d29360d8k_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Q32 BIO INC. Date: December 19, 2025 By: /s/ Jodie Morrison Name: Jodie Morrison Title: Chief Executive Officer